CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award 10b5-1 | +37,401 | 160,557 | ||
| 2026-02-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award | +10,051 | 62,171 | ||
| 2026-02-27 | Sheena Jonathan Director | Grant or award 10b5-1 | +2,103 | 265,264 | ||
| 2026-02-27 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Grant or award | +29,920 | 2,310,772 | ||
| 2026-02-03 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −1,179 | $230.77 | $272K | 180,496 |
| 2026-02-03 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −2,415 | $231.14 | $558K | 178,081 |
| 2026-02-03 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,639 | $230.77 | $378K | 137,847 |
| 2026-02-03 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,334 | $230.77 | $308K | 223,813 |
| 2026-02-03 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −4,725 | $230.77 | $1.1M | 123,156 |
| 2026-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,268 | $230.77 | $293K | 57,791 |
| 2026-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −700 | $225.25 | $158K | 57,091 |
| 2026-02-03 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −4,971 | $227.45 | $1.1M | 52,120 |
| 2026-02-03 | Sheena Jonathan Director | Sale 10b5-1 | −435 | $230.77 | $100K | 263,161 |
| 2026-02-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −80 | $228.50 | $18K | 142,406 |
| 2026-02-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −878 | $229.96 | $202K | 141,528 |
| 2026-02-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −576 | $230.84 | $133K | 140,952 |
| 2026-02-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −850 | $232.33 | $197K | 140,102 |
| 2026-02-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −600 | $233.24 | $140K | 139,502 |
| 2026-02-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −16 | $234.00 | $4K | 139,486 |
| 2026-02-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −6,631 | $229.08 | $1.5M | 206,549 |
Page 26 of 39 · 767 trades